Lexicon Pharmaceuticals
LXRX
#6234
Rank
ยฃ0.75 B
Marketcap
ยฃ1.70
Share price
-1.74%
Change (1 day)
89.36%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -ยฃ0.05217

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.05253. In 2025 the company made an earnings per share (EPS) of -ยฃ0.11 an increase over its 2024 EPS that were of -ยฃ0.48.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.05217-50.34%
2025-ยฃ0.11-78.12%
2024-ยฃ0.48-20%
2023-ยฃ0.6031.15%
2022-ยฃ0.46-0%
2021-ยฃ0.4610.91%
2020-ยฃ0.41-145.08%
2019ยฃ0.92-206.09%
2018-ยฃ0.86-5.74%
2017-ยฃ0.92-10.95%
2016-ยฃ1.032640%
2015-ยฃ0.03752-96.34%
2014-ยฃ1.02-2.53%
2013-ยฃ1.05-9.09%
2012-ยฃ1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ13.67-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.15-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ31.92-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ4.59 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ5.88-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01501-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.56 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.05-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ1,228 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA